Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape
Authors
Keywords
-
Journal
PLoS Pathogens
Volume 9, Issue 5, Pages e1003364
Publisher
Public Library of Science (PLoS)
Online
2013-05-17
DOI
10.1371/journal.ppat.1003364
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Crystal structure of glycoprotein C from Rift Valley fever virus
- (2013) M. Dessau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives
- (2012) Christoph Welsch et al. GUT
- Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
- (2012) Laura E. McCoy et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Antiviral strategies in hepatitis C virus infection
- (2012) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing Antibody
- (2012) J. A. Potter et al. JOURNAL OF VIROLOGY
- Structure of Hepatitis C Virus Envelope Glycoprotein E2 Antigenic Site 412 to 423 in Complex with Antibody AP33
- (2012) L. Kong et al. JOURNAL OF VIROLOGY
- Cooperativity in Virus Neutralization by Human Monoclonal Antibodies to Two Adjacent Regions Located at the Amino Terminus of Hepatitis C Virus E2 Glycoprotein
- (2012) Z. Keck et al. JOURNAL OF VIROLOGY
- Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1
- (2012) L. Kong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of a Pestivirus Envelope Glycoprotein E2 Clarifies Its Role in Cell Entry
- (2012) Kamel El Omari et al. Cell Reports
- Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate
- (2012) Zhen-yong Keck et al. PLoS Pathogens
- Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
- (2012) Trevor J. Morin et al. PLoS Pathogens
- Data processing and analysis with theautoPROCtoolbox
- (2011) Clemens Vonrhein et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Hepatitis C Virus Is Primed by CD81 Protein for Low pH-dependent Fusion
- (2011) Nishi R. Sharma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization
- (2011) A. W. Tarr et al. JOURNAL OF VIROLOGY
- Mapping a Region of Hepatitis C Virus E2 That Is Responsible for Escape from Neutralizing Antibodies and a Core CD81-Binding Region That Does Not Tolerate Neutralization Escape Mutations
- (2011) Z.-Y. Keck et al. JOURNAL OF VIROLOGY
- A genetically humanized mouse model for hepatitis C virus infection
- (2011) Marcus Dorner et al. NATURE
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Association of anti-E1E2 antibodies with spontaneous recovery or sustained viral response to therapy in patients infected with hepatitis C virus
- (2010) Ndiémé Ndongo et al. HEPATOLOGY
- Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation
- (2010) Samira Fafi-Kremer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of N-Linked Glycans in the Functions of Hepatitis C Virus Envelope Proteins Incorporated into Infectious Virions
- (2010) F. Helle et al. JOURNAL OF VIROLOGY
- Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
- (2010) Paul Y Kwo et al. LANCET
- Telaprevir for Previously Treated Chronic HCV Infection
- (2010) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficient method for production of high yields of Fab fragments in Drosophila S2 cells
- (2010) M. Backovic et al. PROTEIN ENGINEERING DESIGN & SELECTION
- The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule
- (2010) Thomas Krey et al. PLoS Pathogens
- Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus
- (2009) Kimberly A. Dowd et al. GASTROENTEROLOGY
- Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity
- (2009) P. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted
- (2008) Elizabeth C. Verna et al. Clinics in Liver Disease
- Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver–chimeric mice from infection with a homologous hepatitis C virus strain
- (2008) Thomas Vanwolleghem et al. HEPATOLOGY
- IMGT(R), the international ImMunoGeneTics information system(R)
- (2008) M.-P. Lefranc et al. NUCLEIC ACIDS RESEARCH
- In vitro selection of a neutralization-resistant hepatitis C virus escape mutant
- (2008) M. Gal-Tanamy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure-based antigen design: a strategy for next generation vaccines
- (2008) Philip R. Dormitzer et al. TRENDS IN BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation